A significant increase in VCAM-1 levels in SSc-PAH with respect to healthy subjects was also reported in a subsequent study, although no difference was detected between SSc patients with or without PAH, suggesting that this molecule cannot be considered as a biomarker of SSc-related PAH [33]. Here, VCAM1 is linked to systemic sclerosis.